The monoclonal antibodies in veterinary health market face growth opportunities due to rising animal chronic diseases and pet ...

In the treatment of inflammatory bowel disease, synthetic mucus gels can be used to deliver monoclonal antibodies without inducing broad immunosuppression.

This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...

NMPA accepts Akeso’s supplemental New Drug Application for gumokimab to treat active ankylosing spondylitis: Hong Kong Wednesday, January 21, 2026, 12:00 Hrs [IST] Akeso Inc, a ...

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

A look at the clinical progress of anti-Aβ monoclonal antibodies and how precision delivery is shaping the next generation of ...

America has an Alzheimer’s problem, devastating families and driving soaring healthcare costs. More than 7 million people over 65 years old live with Alzheimer’s dementia today, a number predicted to ...

OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) Nantes, France, January 21, ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, ...

The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...

As cancer cases climb steadily across India, lower-cost biosimilars like Tishtha could reshape access to life-saving immunotherapy.